Presilium Private Wealth’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Presilium Private Wealth's NVS Position: Q2 2026 in Review
Presilium Private Wealth reduced its Novartis (NVS) stake by 0.04% in Q2 2026, selling an estimated $300 and leaving 4,603 shares worth $721K. The position accounts for 0.11% of the portfolio, ranked #48.
Presilium Private Wealth first reported a position in NVS in Q1 2026 and has held it in 2 quarters since. 1,610 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Presilium Private Wealth held 4,603 shares of Novartis worth $721K as of Q2 2026.
- Presilium Private Wealth sold 2 Novartis shares in Q2 2026, an estimated $300.
- Novartis made up 0.11% of Presilium Private Wealth's portfolio in Q2 2026, its #48 holding.
- Presilium Private Wealth first reported a position in Novartis in Q1 2026 and has held it in 2 quarters since.
- 1,610 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Presilium Private Wealth's 13F filing for Q2 2026, filed 22 Jul 2026.